help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyamoto, K.
Right arrow Articles by Adamis, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyamoto, K.
Right arrow Articles by Adamis, A. P.
(American Journal of Pathology. 2000;156:1733-1739.)
© 2000 American Society for Investigative Pathology

Regular Articles

Vascular Endothelial Growth Factor (VEGF)-Induced Retinal Vascular Permeability Is Mediated by Intercellular Adhesion Molecule-1 (ICAM-1)

Kazuaki Miyamoto*{dagger}, Samer Khosrof*{dagger}, Sven-Erik Bursell{ddagger}, Yasufumi Moromizato*{dagger}, Lloyd Paul Aiello{ddagger}, Yuichiro Ogura§ and Anthony P. Adamis*{dagger}

From the Laboratory for Surgical Research,*
Children’s Hospital, Harvard Medical School, Boston, Massachusetts; the Department of Ophthalmology,{dagger}
Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts; the Department of Ophthalmology,{ddagger}
Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts; and the Department of Ophthalmology,§
Nagoya City University Medical School, Nagoya, Japan

Two prominent vascular endothelial growth factor (VEGF)-induced retinal effects are vascular permeability and capillary nonperfusion. The mechanisms by which these effects occur are not completely known. Using a rat model, we show that intravitreous injections of VEGF precipitate an extensive retinal leukocyte stasis (leukostasis) that coincides with enhanced vascular permeability and capillary nonperfusion. The leukostasis is accompanied by the up-regulation of intercellular adhesion molecule-1 expression in the retina. The inhibition of intercellular adhesion molecule-1 bioactivity with a neutralizing antibody prevents the permeability and leukostasis increases by 79% and 54%, respectively. These data are the first to demonstrate that a nonendothelial cell type contributes to VEGF-induced vascular permeability. Additionally, they identify a potential mechanism for VEGF-induced retinal capillary nonperfusion.




This article has been cited by other articles:


Home page
 IOVSHome page
D. Mizuno, A. Matsubara, and Y. Ogura
Effect of Posterior Sub-Tenon Administration of Triamcinolone Acetonide on Leukocyte Dynamics in Rat Retinal Microcirculation after Panretinal Photocoagulation
Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2127 - 2133.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. J. Wang, S. X. Zhang, R. Mott, Y. Chen, R. R. Knapp, W. Cao, and J.-x. Ma
Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1166 - F1173.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. Skondra, K. Noda, L. Almulki, F. Tayyari, S. Frimmel, T. Nakazawa, I. K. Kim, S. Zandi, K. L. Thomas, J. W. Miller, et al.
Characterization of Azurocidin as a Permeability Factor in the Retina: Involvement in VEGF-Induced and Early Diabetic Blood-Retinal Barrier Breakdown
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 726 - 731.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Koto, N. Nagai, H. Mochimaru, T. Kurihara, K. Izumi-Nagai, S. Satofuka, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, et al.
Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4328 - 4334.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Mizuno, A. Nishiwaki, H. Morita, T. Miyake, and Y. Ogura
Effects of Periocular Administration of Triamcinolone Acetonide on Leukocyte-Endothelium Interactions in the Ischemic Retina
Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2831 - 2836.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
R B Bhisitkul
Vascular endothelial growth factor biology: clinical implications for ocular treatments.
Br. J. Ophthalmol., December 1, 2006; 90(12): 1542 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. Muranaka, Y. Yanagi, Y. Tamaki, T. Usui, N. Kubota, A. Iriyama, Y. Terauchi, T. Kadowaki, and M. Araie
Effects of Peroxisome Proliferator-Activated Receptor {gamma} and Its Ligand on Blood-Retinal Barrier in a Streptozotocin-Induced Diabetic Model.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4547 - 4552.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. E. van Eeden, L. B. G. Tee, S. Lukehurst, C.-M. Lai, E. P. Rakoczy, L. D. Beazley, and S. A. Dunlop
Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4638 - 4645.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. C. Clermont, M. Cahill, H. Salti, S. L. Rook, C. Rask-Madsen, L. Goddard, J. S. Wong, D. Bursell, S. E. Bursell, and L. P. Aiello
Hepatocyte Growth Factor Induces Retinal Vascular Permeability via MAP-Kinase and PI-3 Kinase without Altering Retinal Hemodynamics.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2701 - 2708.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
K. Masuzawa, S. Jesmin, S. Maeda, S. Zaedi, N. Shimojo, T. Miyauchi, and K. Goto
Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1090 - 1094.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Economopoulou, K. Bdeir, D. B. Cines, F. Fogt, Y. Bdeir, J. Lubkowski, W. Lu, K. T. Preissner, H.-P. Hammes, and T. Chavakis
Inhibition of pathologic retinal neovascularization by {alpha}-defensins
Blood, December 1, 2005; 106(12): 3831 - 3838.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
C. S. Wong and A. J. Van der Kogel
MECHANISMS OF RADIATION INJURY TO THE CENTRAL NERVOUS SYSTEM: IMPLICATIONS FOR NEUROPROTECTION
Mol. Interv., October 1, 2004; 4(5): 273 - 284.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
N. Maar, A. Luksch, A. Graebe, E. Ergun, B. Wimpissinger, M. Tittl, P. Vecsei, M. Stur, and L. Schmetterer
Effect of Laser Photocoagulation on the Retinal Vessel Diameter in Branch and Macular Vein Occlusion
Arch Ophthalmol, July 1, 2004; 122(7): 987 - 991.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. C. Mamputu and G. Renier
Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants
J. Leukoc. Biol., June 1, 2004; 75(6): 1062 - 1069.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Miyahara, J. Kiryu, K. Yamashiro, K. Miyamoto, F. Hirose, H. Tamura, H. Katsuta, K. Nishijima, A. Tsujikawa, and Y. Honda
Simvastatin Inhibits Leukocyte Accumulation and Vascular Permeability in the Retinas of Rats with Streptozotocin-Induced Diabetes
Am. J. Pathol., May 1, 2004; 164(5): 1697 - 1706.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Usui, S. Ishida, K. Yamashiro, Y. Kaji, V. Poulaki, J. Moore, T. Moore, S. Amano, Y. Horikawa, D. Dartt, et al.
VEGF164(165) as the Pathological Isoform: Differential Leukocyte and Endothelial Responses through VEGFR1 and VEGFR2
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 368 - 374.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Dandona, A. Aljada, P. Mohanty, H. Ghanim, A. Bandyopadhyay, and A. Chaudhuri
Insulin Suppresses Plasma Concentration of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9
Diabetes Care, December 1, 2003; 26(12): 3310 - 3314.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. C. B. Moore, J. E. Moore, Y. Kaji, N. Frizzell, T. Usui, V. Poulaki, I. L. Campbell, A. W. Stitt, T. A. Gardiner, D. B. Archer, et al.
The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4457 - 4464.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Perelman, S. K. Selvaraj, S. Batra, L. R. Luck, A. Erdreich-Epstein, T. D. Coates, V. K. Kalra, and P. Malik
Placenta growth factor activates monocytes and correlates with sickle cell disease severity
Blood, August 15, 2003; 102(4): 1506 - 1514.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
S. Ishida, T. Usui, K. Yamashiro, Y. Kaji, S. Amano, Y. Ogura, T. Hida, Y. Oguchi, J. Ambati, J. W. Miller, et al.
VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization
J. Exp. Med., August 4, 2003; 198(3): 483 - 489.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
E. Sakurai, H. Taguchi, A. Anand, B. K. Ambati, E. S. Gragoudas, J. W. Miller, A. P. Adamis, and J. Ambati
Targeted Disruption of the CD18 or ICAM-1 Gene Inhibits Choroidal Neovascularization
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2743 - 2749.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Ishida, T. Usui, K. Yamashiro, Y. Kaji, E. Ahmed, K. G. Carrasquillo, S. Amano, T. Hida, Y. Oguchi, and A. P. Adamis
VEGF164 Is Proinflammatory in the Diabetic Retina
Invest. Ophthalmol. Vis. Sci., May 1, 2003; 44(5): 2155 - 2162.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
F Mori, T Hikichi, T Nagaoka, J Takahashi, N Kitaya, and A Yoshida
Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats
Br. J. Ophthalmol., October 1, 2002; 86(10): 1172 - 1174.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. T. Rosenbaum
Sugar Creates a Sticky Business: Round Up the Usual Suspects
Am. J. Pathol., May 1, 2002; 160(5): 1547 - 1550.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. M. Joussen, V. Poulaki, A. Tsujikawa, W. Qin, T. Qaum, Q. Xu, Y. Moromizato, S.-E. Bursell, S. J. Wiegand, J. Rudge, et al.
Suppression of Diabetic Retinopathy with Angiopoietin-1
Am. J. Pathol., May 1, 2002; 160(5): 1683 - 1693.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. Nonaka, J. Kiryu, A. Tsujikawa, K. Yamashiro, K. Nishijima, H. Kamizuru, Y. Ieki, K. Miyamoto, H. Nishiwaki, Y. Honda, et al.
Inflammatory Response after Scatter Laser Photocoagulation in Nonphotocoagulated Retina
Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1204 - 1209.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
A P Adamis
Is diabetic retinopathy an inflammatory disease?
Br. J. Ophthalmol., April 1, 2002; 86(4): 363 - 365.
[Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
B Sander, M Larsen, C Engler, C Strom, B Moldow, N Larsen, and H Lund-Andersen
Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy
Br. J. Ophthalmol., March 1, 2002; 86(3): 316 - 320.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. M. Joussen, V. Poulaki, W. Qin, B. Kirchhof, N. Mitsiades, S. J. Wiegand, J. Rudge, G. D. Yancopoulos, and A. P. Adamis
Retinal Vascular Endothelial Growth Factor Induces Intercellular Adhesion Molecule-1 and Endothelial Nitric Oxide Synthase Expression and Initiates Early Diabetic Retinal Leukocyte Adhesion in Vivo
Am. J. Pathol., February 1, 2002; 160(2): 501 - 509.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. M. Joussen, W.-D. Beecken, Y. Moromizato, A. Schwartz, B. Kirchhof, and V. Poulaki
Inhibition of Inflammatory Corneal Angiogenesis by TNP-470
Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2510 - 2516.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Qaum, Q. Xu, A. M. Joussen, M. W. Clemens, W. Qin, K. Miyamoto, H. Hassessian, S. J. Wiegand, J. Rudge, G. D. Yancopoulos, et al.
VEGF-initiated Blood-Retinal Barrier Breakdown in Early Diabetes
Invest. Ophthalmol. Vis. Sci., September 1, 2001; 42(10): 2408 - 2413.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Q. Xu, T. Qaum, and A. P. Adamis
Sensitive Blood-Retinal Barrier Breakdown Quantitation Using Evans Blue
Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 789 - 794.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
C. Schwesinger, C. Yee, R. M. Rohan, A. M. Joussen, A. Fernandez, T. N. Meyer, V. Poulaki, J. J. K. Ma, T. M. Redmond, S. Liu, et al.
Intrachoroidal Neovascularization in Transgenic Mice Overexpressing Vascular Endothelial Growth Factor in the Retinal Pigment Epithelium
Am. J. Pathol., March 1, 2001; 158(3): 1161 - 1172.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.